Skip to Content

Sonoma Pharmaceuticals Inc SNOA

Morningstar Rating
$0.15 −0.01 (4.95%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SNOA is trading at a 66% discount.
Price
$0.15
Fair Value
$5.82
Uncertainty
Extreme
1-Star Price
$2.52
5-Star Price
$4.50
Economic Moat
Rfvq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SNOA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.15
Day Range
$0.140.16
52-Week Range
$0.121.52
Bid/Ask
$0.15 / $0.15
Market Cap
$2.28 Mil
Volume/Avg
272,484 / 1.9 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.08
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
171

Valuation

Metric
SNOA
Price/Earnings (Normalized)
Price/Book Value
0.31
Price/Sales
0.08
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
SNOA
Quick Ratio
1.72
Current Ratio
4.07
Interest Coverage
Quick Ratio
SNOA

Profitability

Metric
SNOA
Return on Assets (Normalized)
−30.51%
Return on Equity (Normalized)
−68.39%
Return on Invested Capital (Normalized)
−62.90%
Return on Assets
SNOA
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ASwqk$90.3 Bil
MKKGY
Merck KGaA ADRVltwpk$74.8 Bil
HLN
Haleon PLC ADRLyl$38.3 Bil
VTRS
Viatris IncNtjyw$16.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRMtwp$12.9 Bil
CTLT
Catalent IncBlmjjld$10.6 Bil
PRGO
Perrigo Co PLCHys$4.4 Bil
CURLF
Curaleaf Holdings IncPxbhl$3.9 Bil
PBH
Prestige Consumer Healthcare IncJllxfpc$3.5 Bil
GTBIF
Green Thumb Industries IncBtfy$3.4 Bil

Sponsor Center